(Q35097680)

6 August 2017

Endothelial activation by platelets from sickle cell anemia patients (English)

1 reference

6 August 2017

0 references

0 references

Fabíola Traina

8

0 references

author name string

Renata Proença-Ferreira

1

1 reference

6 August 2017

Ana Flávia Brugnerotto

2

1 reference

6 August 2017

Vanessa Tonin Garrido

3

1 reference

6 August 2017

Venina Marcela Dominical

4

1 reference

6 August 2017

Daiana Morelli Vital

5

1 reference

6 August 2017

Marilene de Fátima Reis Ribeiro

6

1 reference

6 August 2017

Melissa Ercolin dos Santos

7

1 reference

6 August 2017

Sara T Olalla-Saad

9

1 reference

6 August 2017

Fernando Ferreira Costa

10

1 reference

6 August 2017

Nicola Conran

11

1 reference

6 August 2017

language of work or name

English

0 references

publication date

13 February 2014

1 reference

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

2

1 reference

6 August 2017

e89012

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

start time

13 February 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Interplay between coagulation and vascular inflammation in sickle cell disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Big strokes in small persons

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Tissue factor expression by endothelial cells in sickle cell anemia

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia.

9 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Platelet activation in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Increased adhesive properties of platelets in sickle cell disease: roles for alphaIIb beta3-mediated ligand binding, diminished cAMP signalling and increased phosphodiesterase 3A activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Thrombophilia in sickle cell disease: the red cell connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Therapeutic effect of aspirin in sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Phase I study of eptifibatide in patients with sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0089012

Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923877

Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion

27 September 2018

1 reference

12 December 2020

Thrombogenesis in sickle cell disease

1 reference

12 December 2020

Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease

1 reference

12 December 2020

Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry

1 reference

12 December 2020

Abnormalities of platelet aggregation in sickle cell disease

1 reference

12 December 2020

Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises

1 reference

12 December 2020

Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis

1 reference

12 December 2020

Platelet function in sickle cell disease during steady state

1 reference

12 December 2020

Enhanced thrombin generation in children with sickle cell disease

1 reference

12 December 2020

Disturbance of plasma and platelet thrombospondin levels in sickle cell disease

1 reference

12 December 2020

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia

1 reference

12 December 2020

Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation

1 reference

12 December 2020

Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0089012

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference